Increasing
threats from both pathogenic infections and antibiotic
resistance highlight the pressing demand for nonantibiotic agents
and alternative therapies. Herein, we report several new phenothiazinium-based
derivatives, which could be readily synthesized via fragment-based
assembly, which exhibited remarkable bactericidal activities both
in vitro and in vivo. Importantly, in contrast to numerous clinically
and preclinically used antibacterial photosensitizers, these compounds
were able to eliminate various types of microorganisms, including
Gram-(+) Staphylococcus aureus (S. aureus), Gram-(−) Escherichia
coli, multidrug-resistant S. aureus, and their associated biofilms, at low drug and light dosages (e.g.,
0.21 ng/mL in vitro and 1.63 ng/cm2 in vivo to eradicate S. aureus at 30 J/cm2). This study thus
unveils the potential of these novel phenothiaziniums as potent antimicrobial
agents for highly efficient photodynamic antibacterial chemotherapy.